Recent ImmunoPrecise News & Releases

ImmunoPrecise Announces $2 Million Financing

August 22nd, 2018

Victoria, British Columbia, Canada, August 22, 2018 – IMMUNOPRECISE ANTIBODIES LTD.(“ImmunoPrecise” or “IPA”) (TSX VENTURE: IPA)(OTC PINK: IPATF) announces that it proposes to complete a non-brokered ...

Read more

More ImmunoPrecise Antibodies Ltd. News and Events